Preview

B.E. Study

Satisfactory Essays
Open Document
Open Document
614 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
B.E. Study
Bio-Equivalence

Introduction

Bioequivalence study data has long been a standard part of the dossiers for approval of generic products in all regulated markets, which includes the highly developed countries like United States of America, Europe, Japan, Australia and South Africa. Even the rest of world (ROW) markets are now asking for bioequivalence data to be submitted as part of the regulatory dossiers for approval of the generic products.
Looking at bioequivalence studies beyond just being a regulatory requirement, bioequivalence studies which are conducted properly can help establish the product as a reputed brand because the therapeutic efficacy of a well-developed and bioequivalent product will be far better than a bio-in equivalent product. So bioequivalence studies not only help you get the regulatory approvals to enter a market, a bioequivalent product will also help establish the brand value and reputation of the company in that market.
A bioequivalence study establishes that the rate and extent of the drug being absorbed into the system is same to that of the innovator product with which extensive clinical trials have been conducted to establish as therapeutic efficacy and safety profile by the innovator company. For most molecules the pharmacodynamics are closely linked to the pharmacokinetic profile (PK PD correlation) thus if the pharmacokinetic profile is matched with that of the innovator product, It is expected to have the same efficacy and safety profile.
This gives the generic manufacturers a huge saving in the costs which goes into developing new drug by taking it through the various stages of preclinical and clinical evaluation to establish safety and efficacy.
Submitting a bioequivalence study along with regulatory dossier is one of the requirements for product registration in most of the countries and pharma companies always look for a right partner who can help them in conduct of these studies in cost effective and timely manner

You May Also Find These Documents Helpful

  • Satisfactory Essays

    Biopure needs to determine the best course of action to launch two new products, Oxyglobin a blood substitute for the veterinary market and Hemopure a blood substitute for the human market. Oxyglobin has been approved for commercial use and is ready for launch while Hemopure is expected to be FDA approved within two years. Biopure needs to decide whether and when to launch Oxyglobin. If decided to launch, the ability to price Oxyglobin appropriately is critical to minimize the impact of prospective launch for Hemopure. We believe Oxyglobin should be launched immediately because…

    • 1016 Words
    • 5 Pages
    Satisfactory Essays
  • Satisfactory Essays

    TCO 2 deals with new experimental drugs and the steps required to bring new drugs to market. The first application paper deals with this as well. Describe the steps that are required to bring a new pharmaceutical to market. Address topics like human testing, the role of the FDA in approving new drugs, and the cost incurred by drug companies when developing new drugs.…

    • 660 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Biopure Case Analysis

    • 1200 Words
    • 5 Pages

    Competitors, if they get the approval, will launch the product in late 1999. Whereas Biopure can release their product only in 2000…

    • 1200 Words
    • 5 Pages
    Satisfactory Essays
  • Best Essays

    References: David, F.I. & PL, J. (2013). Compound Pharmacy Regulatory Update: Senate to Vote on…

    • 3430 Words
    • 14 Pages
    Best Essays
  • Satisfactory Essays

    Questions 6

    • 535 Words
    • 2 Pages

    Underutilization of new effective drugs is a serious concern for pharmaceutical companies. There are many restrictions on pharmaceuticals companies to make their drug available for everyone. Certain restrictions like Medicaid will only allow specific medicine to be reimbursable. If a…

    • 535 Words
    • 2 Pages
    Satisfactory Essays
  • Good Essays

    While the likeliness of participating in trials, it also increases the larger pool of patients. The larger the pool of patients, the more accurate the statistics are. Furthermore, the U.S. pharmaceutical companies have discovered the qualities of their stats from overseas countries are the same, but they can get those same results for a lower price.…

    • 459 Words
    • 2 Pages
    Good Essays
  • Powerful Essays

    This has led to the convention of the NSURE (Nonprescription Safe Use Regulatory Expansion) initiative, which aims to expand the regulatory constraints associated with the non-prescription drug category, in hopes of providing increased access to adequate medical care for the public. The NSURE initiative was conceptualized to aid the process of Rx-to-OTC switches by expanding the ‘Conditions of Safe Use’. According to the presentation of Theresa M. Michele, MD, Director, Division of Nonprescription Clinical Evaluation of the FDA, at a conference on OTC drugs held in October 2014, the existing switch process has a few limitations, mentioned below. • The purchase decision for the OTC drugs is based only on the information conveyed through the Drug Facts label and the principal display panel • The switch process is restricted in its communication with the consumer and doesn’t take…

    • 1315 Words
    • 6 Pages
    Powerful Essays
  • Better Essays

    Many of the world's pharmaceuticals are tested on a variety of animals from dogs to rats. The physiological and genetic similarities an animal's has with humans, allows them to be the perfect test subject. Even the most obscure similarity can warrant a licence to test on animals…

    • 923 Words
    • 4 Pages
    Better Essays
  • Powerful Essays

    Biormedia Inc.

    • 1341 Words
    • 6 Pages

    All of BioRemedia Inc’s activities are governed by competition laws (known in the United States as “antitrust” laws) and trade regulation laws. It is important for us to know these laws and regulations…

    • 1341 Words
    • 6 Pages
    Powerful Essays
  • Powerful Essays

    The FDA (Food and Drug Administration) is one of the most advanced pharmaceutical systems in the world. For a new drug to pass the FDA must first approve multiple variables surrounding the new medication. For instance, the drug company must provide proper evidence to support that their products, both generic and name brand, work properly and have more…

    • 1833 Words
    • 8 Pages
    Powerful Essays
  • Satisfactory Essays

    Vertex Case Team 2

    • 543 Words
    • 6 Pages

    probability, pralnacasan deal with Aventis, oral not injection, good antiinflammatory drug has high potential, relatively quick to market (2008),…

    • 543 Words
    • 6 Pages
    Satisfactory Essays
  • Good Essays

    For example, it is reducing the cost and time; as inventing new drug needs tons of studies to increase the affinity and selectivity of these drugs together with the safety through other aspects, which are available for those drugs; consequently no need to reproduce them.…

    • 397 Words
    • 2 Pages
    Good Essays
  • Better Essays

    Such tools as pharmaceutical and insurance companies, specialty fields, training groups, and rehabilitation concentrate on the individuals needs pertaining to treatment. The pharmaceutical companies provide the medications to control or cure a particular illness or ailment. Prescriptions can cost anywhere from $3 (Wal-Mart, and/or CVS generic) to $100+ for a single bottle of medication. Most prescriptions are prescribed after the person has already been diagnosed and is ready for treatment. These treatments can also assist in maintaining a particular level of health. The insurance…

    • 1408 Words
    • 6 Pages
    Better Essays
  • Satisfactory Essays

    Biopure

    • 1060 Words
    • 5 Pages

    Competitors, if they get the approval, will launch the product in late 1999. Whereas Biopure can release their product only in 2000…

    • 1060 Words
    • 5 Pages
    Satisfactory Essays
  • Good Essays

    Usually in the case of the pharmaceutical companies producing and marketing a wider range of drugs would reduce the dependence on the so called specialized drugs.…

    • 830 Words
    • 4 Pages
    Good Essays